Morgan Stanley’s Albireo Pharma Inc ALBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-144,423
| Closed | -$3.12M | – | 7936 |
|
|
2022
Q4 | $3.12M | Buy |
144,423
+21,430
| +17% | +$453K | ﹤0.01% | 4142 |
|
|
2022
Q3 | $2.38M | Sell |
122,993
-30,985
| -20% | -$641K | ﹤0.01% | 4298 |
|
|
2022
Q2 | $3.06M | Buy |
153,978
+99,678
| +184% | +$2.63M | ﹤0.01% | 4194 |
|
|
2022
Q1 | $1.62M | Buy |
54,300
+14,107
| +35% | +$413K | ﹤0.01% | 4670 |
|
|
2021
Q4 | $936K | Buy |
40,193
+21,048
| +110% | +$560K | ﹤0.01% | 5121 |
|
|
2021
Q3 | $597K | Buy |
19,145
+6,149
| +47% | +$190K | ﹤0.01% | 5377 |
|
|
2021
Q2 | $458K | Buy |
12,996
+11,320
| +675% | +$368K | ﹤0.01% | 5581 |
|
|
2021
Q1 | $59K | Sell |
1,676
-13,048
| -89% | -$482K | ﹤0.01% | 6284 |
|
|
2020
Q4 | $552K | Buy |
14,724
+12,740
| +642% | +$463K | ﹤0.01% | 5021 |
|
|
2020
Q3 | $66K | Sell |
1,984
-2,582
| -57% | -$75.2K | ﹤0.01% | 5611 |
|
|
2020
Q2 | $121K | Buy |
4,566
+3,123
| +216% | +$73.7K | ﹤0.01% | 5315 |
|
|
2020
Q1 | $23K | Sell |
1,443
-13,608
| -90% | -$299K | ﹤0.01% | 5768 |
|
|
2019
Q4 | $383K | Buy |
15,051
+11,722
| +352% | +$234K | ﹤0.01% | 5081 |
|
|
2019
Q3 | $66K | Buy |
3,329
+2,835
| +574% | +$73.4K | ﹤0.01% | 5596 |
|
|
2019
Q2 | $16K | Sell |
494
-1,663
| -77% | -$55.6K | ﹤0.01% | 6009 |
|
|
2019
Q1 | $70K | Sell |
2,157
-12,336
| -85% | -$332K | ﹤0.01% | 5531 |
|
|
2018
Q4 | $355K | Sell |
14,493
-728
| -5% | -$19.2K | ﹤0.01% | 5010 |
|
|
2018
Q3 | $502K | Sell |
15,221
-4,589
| -23% | -$150K | ﹤0.01% | 5000 |
|
|
2018
Q2 | $703K | Buy |
19,810
+11,154
| +129% | +$361K | ﹤0.01% | 4862 |
|
|
2018
Q1 | $282K | Sell |
8,656
-866
| -9% | -$29.2K | ﹤0.01% | 5316 |
|
|
2017
Q4 | $244K | Buy |
9,522
+9,065
| +1,984% | +$230K | ﹤0.01% | 5340 |
|
|
2017
Q3 | $10K | Buy |
+457
| New | +$10.9K | ﹤0.01% | 6176 |
|
|
2017
Q1 | – | Sell |
-451
| Closed | -$8K | – | 6641 |
|
|
2016
Q4 | $8K | Buy |
+451
| New | +$9.36K | ﹤0.01% | 6209 |
|
|
2016
Q2 | – | Sell |
-4
| Closed | – | – | 6711 |
|
|
2016
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 6780 |
|
|
2015
Q4 | $0 | Sell |
4
-3
| -43% | -$31 | ﹤0.01% | 6850 |
|
|
2015
Q3 | $0 | Sell |
7
-3
| -30% | -$76 | ﹤0.01% | 6768 |
|
|
2015
Q2 | $0 | Buy |
10
+9
| +900% | +$302 | ﹤0.01% | 6794 |
|
|
2015
Q1 | $0 | Sell |
1
-36
| -97% | -$1.52K | ﹤0.01% | 6696 |
|
|
2014
Q4 | $1K | Sell |
37
-42
| -53% | -$1.84K | ﹤0.01% | 6509 |
|
|
2014
Q3 | $4K | Buy |
79
+9
| +13% | +$517 | ﹤0.01% | 6372 |
|
|
2014
Q2 | $5K | Buy |
70
+67
| +2,233% | +$4.66K | ﹤0.01% | 6293 |
|
|
2014
Q1 | $0 | Sell |
3
-196
| -98% | -$17.8K | ﹤0.01% | 6576 |
|
|
2013
Q4 | $13K | Buy |
+199
| New | +$14.6K | ﹤0.01% | 5985 |
|
|
2013
Q3 | – | Sell |
-1,610
| Closed | -$202K | – | 5407 |
|
|
2013
Q2 | $202K | Buy |
+1,610
| New | +$168K | ﹤0.01% | 4834 |
|
Other funds holding ALBO
Morgan Stanley's ALBO Position: Q1 2023 in Review
Morgan Stanley sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 144,423 shares — an estimated $3.12M sold.
Morgan Stanley first reported a position in ALBO in Q2 2013 and held it in 34 quarters. The position peaked at $3.12M in Q4 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.
- Morgan Stanley reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
- Morgan Stanley sold 144,423 Albireo Pharma Inc shares in Q1 2023, an estimated $3.12M.
- Morgan Stanley first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 34 quarters.
- Morgan Stanley's Albireo Pharma Inc position peaked at $3.12M in Q4 2022.
- 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.